Aucta Pharmaceuticals China

China
Shaxi, Fujian, China

Company profile

Aucta Pharmaceuticals China company profile

Aucta is a pharmaceutical company that uses the 505(b)(2) regulatory pathway to create better products from proven molecules. Aucta is developing new therapeutics through innovation, including new dosage forms, dosing regimens, and indications. It develops and commercializes branded specialty products as well as technology platform-based niche generics. Aucta's therapeutic focus is on CNS disorders, Ophthalmics, and Inhalation Therapy. We are committed to being patient-centric by bringing improved versions of proven molecules to market regularly.

Business identity

Contact email
[email protected]
Phone number
+86 21 58585606
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2012-03-01, Month

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$15.6M
Last funding
Series A / $15.6M / 2021-11-04
Last equity funding
Series A / $15.6M
Investors
6
Lead investors
1
Founders
1
Articles
5

Categories and groups

Founders and investors

Founders

Shoufeng Li

Lead investors

Tianjin Haida Venture Capital Management

Investors

Cowin VentureGrand Yangtze CapitalSangel CapitalSDIC Venture CapitalTianjin Haida Venture Capital Management